# Kura Oncology, Inc.: Form 8-K, filed May 24, 2024

- Company: [Kura Oncology, Inc.](/companies/kura.md) (CIK 1422143)
- Form: 8-K
- Filed: 2024-05-24
- Accepted by EDGAR: May 24, 2024, 16:06 ET
- Period: 2024-05-24
- Accession: 0001193125-24-147030
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1422143/000119312524147030/d842527d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1422143/000119312524147030/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1422143/000119312524147030/d842527d8k.htm

Filed May 24, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-147030. Last ingested by Listed: Nov 11, 2026, 03:30 ET. No prices; not investment advice.
